These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32905153)

  • 21. Preliminary Safety and Tolerability of a Novel Subcutaneous Intrathecal Catheter System for Repeated Outpatient Dosing of Nusinersen to Children and Adults With Spinal Muscular Atrophy.
    Strauss KA; Carson VJ; Brigatti KW; Young M; Robinson DL; Hendrickson C; Fox MD; Reed RM; Puffenberger EG; Mackenzie W; Miller F
    J Pediatr Orthop; 2018; 38(10):e610-e617. PubMed ID: 30134351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound-guided cervical puncture for nusinersen administration in adolescents.
    Ortiz CB; Kukreja KU; Lotze TE; Chau A
    Pediatr Radiol; 2019 Jan; 49(1):136-140. PubMed ID: 30167764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathecal nusinersen administration in adult spinal muscular atrophy patients with complex spinal anatomy.
    Cordts I; Lingor P; Friedrich B; Pernpeintner V; Zimmer C; Deschauer M; Maegerlein C
    Ther Adv Neurol Disord; 2020; 13():1756286419887616. PubMed ID: 32010224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population Pharmacokinetics of Nusinersen in the Cerebral Spinal Fluid and Plasma of Pediatric Patients With Spinal Muscular Atrophy Following Intrathecal Administrations.
    Luu KT; Norris DA; Gunawan R; Henry S; Geary R; Wang Y
    J Clin Pharmacol; 2017 Aug; 57(8):1031-1041. PubMed ID: 28369979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nusinersen for older patients with spinal muscular atrophy: A real-world clinical setting experience.
    Veerapandiyan A; Eichinger K; Guntrum D; Kwon J; Baker L; Collins E; Ciafaloni E
    Muscle Nerve; 2020 Feb; 61(2):222-226. PubMed ID: 31773738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posterior Spinal Correction and Fusion Surgery in Patients with Spinal Muscular Atrophy-Associated Scoliosis for Whom Treatment with Nusinersen Was Planned.
    Machida S; Miyagi M; Saito W; Matsui A; Imura T; Inoue G; Nakazawa T; Shirasawa E; Ikeda S; Kawakubo A; Kuroda A; Yokozeki Y; Mimura Y; Uchida K; Akazawa T; Takaso M
    Spine Surg Relat Res; 2021; 5(2):109-113. PubMed ID: 33842719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posterior spinal fusion in patients with spinal muscular atrophy: a surgical technique to allow intrathecally inject nusinersen.
    Amico S; Scoscina D; Milazzo I; Martiniani M; Meco L; Siliquini S; Specchia N; Gigante AP
    Minerva Pediatr (Torino); 2023 May; ():. PubMed ID: 37155209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Implication of Dosimetry of Computed Tomography- and Fluoroscopy-Guided Intrathecal Therapy With Nusinersen in Adult Patients With Spinal Muscular Atrophy.
    Kizina K; Stolte B; Totzeck A; Bolz S; Fleischer M; Mönninghoff C; Guberina N; Oldenburg D; Forsting M; Kleinschnitz C; Hagenacker T
    Front Neurol; 2019; 10():1166. PubMed ID: 31787921
    [No Abstract]   [Full Text] [Related]  

  • 29. Intrathecal nusinersen treatment for SMA in a dedicated neuromuscular clinic: an example of multidisciplinary and integrated care.
    Sansone VA; Albamonte E; Salmin F; Casiraghi J; Pirola A; Bettinelli M; Rao F; Mancini L; Tovaglieri N; Fedeli F; Stoia P; Heinen M; Cozzi V; Carraro E; Lunetta C; Di Bari A; Mercuri E;
    Neurol Sci; 2019 Feb; 40(2):327-332. PubMed ID: 30430317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Routine Cerebrospinal Fluid Cytology Reveals Unique Inclusions in Macrophages During Treatment With Nusinersen.
    Gingele S; Hümmert MW; Alvermann S; Jendretzky KF; Bönig L; Brieskorn M; Schwenkenbecher P; Sühs KW; Müschen LH; Osmanovic A; Schreiber-Katz O; Stangel M; Petri S; Skripuletz T
    Front Neurol; 2019; 10():735. PubMed ID: 31354609
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacological and clinical profile of spinal muscular atrophy (SMA) therapeutic drug nusinersen (Spinraza
    Ohmura T; Saeki S; Ogiwara K; Tobita K; Ling Y; Torii S
    Nihon Yakurigaku Zasshi; 2018; 152(3):147-159. PubMed ID: 30185733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scoliosis and spinal muscular atrophy in the new world of medical therapy: providing lumbar access for intrathecal treatment in patients previously treated or undergoing spinal instrumentation and fusion.
    Labianca L; Weinstein SL
    J Pediatr Orthop B; 2019 Jul; 28(4):393-396. PubMed ID: 30932967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrathecal delivery of nusinersen in individuals with complicated spines.
    Cartwright MS; Ward ZT; White EP; West TG
    Muscle Nerve; 2020 Jul; 62(1):114-118. PubMed ID: 32319101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1.
    Pechmann A; Langer T; Wider S; Kirschner J
    Eur J Paediatr Neurol; 2018 Jan; 22(1):122-127. PubMed ID: 29208343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continual cerebrospinal fluid sampling in the neonatal domestic piglet for biomarker and discovery studies.
    Pino MG; Ganguly R; Rich KA; Fox A; Mattox L; Keckley E; Joseph M; Malbrue R; Youngblood B; Krishna V; Kolb SJ
    J Neurosci Methods; 2022 Jan; 366():109403. PubMed ID: 34752813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrathecal administration of nusinersen for spinal muscular atrophy: report of three cases with severe spinal deformity.
    Nakao S; Yamada S; Tsuda K; Yokomizo T; Sato T; Tanoue S; Hiraki T
    JA Clin Rep; 2020 Apr; 6(1):28. PubMed ID: 32314319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modified nusinersen intrathecal injection method: inclusion of a septal needle-free closed infusion connector.
    Zhang Y; Zheng K; Liang C; Zheng R; Chen J; Jiang M; Zhou Z; Zhao Y; Rao M; Yang S; Chen W; Liu L
    Front Neurol; 2023; 14():1234442. PubMed ID: 37808480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment.
    Wurster CD; Günther R; Steinacker P; Dreyhaupt J; Wollinsky K; Uzelac Z; Witzel S; Kocak T; Winter B; Koch JC; Lingor P; Petri S; Ludolph AC; Hermann A; Otto M
    Ther Adv Neurol Disord; 2019; 12():1756286419846058. PubMed ID: 31205491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oblique Intrathecal Injection in Lumbar Spine Surgery: A Technical Note.
    Jewett GAE; Yavin D; Dhaliwal P; Whittaker T; Krupa J; Du Plessis S
    Can J Neurol Sci; 2017 Sep; 44(5):514-517. PubMed ID: 28478791
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.